All lobbying filings
BROWNSTEIN HYATT FARBER SCHRECK, LLP
Lobbying for KYVERNA THERAPEUTICS, INC. · Biopharmaceutical company
Filing
1st Quarter - Report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 19, 2026
Income
$20,000.00
What the client paid this registrant for the period.
Client based in
California
Lobbying activity
1
Outreach regarding cell therapies for autoimmune diseases.